GlassScriptPhysician profile
Gerald Ulysses Matile
NPI 1750326823
$1,766.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $571 · 2021: $719.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.13 | 2019-2021 | |
| Daiichi Sankyo INC. | $172.36 | 2019-2021 | |
| Coopersurgical, INC. | $155.15 | 2020-2021 | |
| Avion Pharmaceuticals | $135.50 | 2019-2021 | |
| Therapeuticsmd, INC. | $89.63 | 2020-2021 | |
| Pfizer INC. | $87.62 | 2019-2021 | |
| Exeltis, USA INC. | $85.81 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.61 | 2019-2021 | |
| Amgen INC. | $69.33 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $63.23 | 2019-2021 | |
| Allergan, INC. | $62.22 | 2019-2020 | |
| Evofem Biosciences, INC. | $50.50 | 2020-2021 | |
| Hologic Sales and Service, LLC | $47.91 | 2019-2021 | |
| Lupin INC. | $39.86 | 2019 | |
| Vertical Pharmaceuticals, LLC | $38.97 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38.32 | 2021 | |
| Ascend Therapeutics US, LLC | $22.94 | 2020 | |
| Millicent US INC | $21.92 | 2021 | |
| Agile Therapeutics, INC. | $19.23 | 2021 | |
| Mayne Pharma Commercial LLC | $19.06 | 2021 | |
| Covidien LP | $18.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.57 | 2019 | |
| Myovant Sciences INC. | $12.75 | 2021 | |
| Zyla Life Sciences, INC. | $11.80 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Matile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.